600873.SH
梅花生物
SSE · Basic Materials · Chemicals - Specialty · CN
CNY 7.87
+1.42%Year over year
Reported trailing growth
- Revenue
- -3.7%
- EBITDA
- —
- EBIT
- -51.7%
- EPS
- -19.6%
- Free cash flow
- -88.2%
- Operating cash flow
- -53.0%
Forward estimates
Based on analyst estimates
- Revenue
- -47.3%
- EBITDA
- -52.2%
- EPS
- -54.0%
Three-year CAGR
- Revenue
- -4.7%
- EBITDA
- -12.8%
- EBIT
- -17.4%
- Net income
- -9.4%
- EPS
- -6.7%
- Free cash flow
- -22.9%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026